| |
| |
|
| Insider
Information: |
Mueller Brian |
| Relationship: |
|
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
81,859 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,368,863 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
81,859 |
|
|
| Total
Value |
$6,368,863 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Financial O... |
2024-03-15 |
71,859 |
|
0 |
Premium* |
|
|
Anthera Pharmaceuticals Inc |
ANTH |
|
2015-12-23 |
10,000 |
2015-12-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
136 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2017-06-22 |
4 |
OE |
$21.51 |
$57,453 |
D/D |
2,671 |
15,556 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2017-06-22 |
4 |
AS |
$100.00 |
$267,100 |
D/D |
(2,671) |
12,885 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2023-03-15 |
4 |
D |
$87.74 |
$237,600 |
D/D |
(2,708) |
59,558 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2012-07-02 |
4 |
AS |
$40.00 |
$110,800 |
D/D |
(2,770) |
15,340 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2012-07-02 |
4 |
OE |
$17.86 |
$49,472 |
D/D |
2,770 |
18,110 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2019-04-05 |
4 |
AS |
$94.00 |
$277,582 |
D/D |
(2,953) |
13,660 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2018-06-22 |
4 |
AS |
$99.50 |
$312,928 |
D/D |
(3,145) |
12,375 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2011-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,160 |
7,336 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2014-11-26 |
4 |
S |
$88.97 |
$302,508 |
D/D |
(3,400) |
4,593 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2013-05-14 |
4 |
OE |
$21.51 |
$75,285 |
D/D |
3,500 |
10,160 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-08-05 |
4 |
AS |
$94.50 |
$330,750 |
D/D |
(3,500) |
30,726 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-08-05 |
4 |
OE |
$67.81 |
$237,335 |
D/D |
3,500 |
34,226 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-11-23 |
4 |
OE |
$67.81 |
$237,335 |
D/D |
3,500 |
32,347 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2016-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,570 |
15,623 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2023-03-16 |
4 |
D |
$93.41 |
$371,118 |
D/D |
(3,973) |
55,585 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2014-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
8,800 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2015-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
12,800 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2012-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,720 |
13,684 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2017-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
4,790 |
18,080 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2013-05-02 |
4 |
OE |
$14.39 |
$70,137 |
D/D |
4,874 |
18,734 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2013-05-14 |
4 |
S |
$70.33 |
$348,045 |
D/D |
(4,947) |
6,660 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2012-02-24 |
4 |
S |
$35.07 |
$175,325 |
D/D |
(5,000) |
8,300 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2012-02-24 |
4 |
OE |
$11.74 |
$58,700 |
D/D |
5,000 |
13,300 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2014-12-02 |
4 |
OE |
$28.23 |
$141,150 |
D/D |
5,000 |
9,593 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2014-12-02 |
4 |
S |
$91.82 |
$459,100 |
D/D |
(5,000) |
4,593 |
0 |
- |
|
136 Records found
|
|
Page 4 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
